Januvia® (Sitagliptin Tablets) – 25 mg | 50 mg | 100 mg

Januvia® is a  DPP-4 inhibitor tablet that helps control blood sugar levels in adults with Type 2 diabetes.

Januvia® (Sitagliptin Tablets) is a prescription oral antidiabetic medication used for the management of type 2 diabetes mellitus. It belongs to the DPP-4 inhibitor class, which works by increasing incretin hormone levels, improving insulin release, and reducing excessive glucose production in the body.

Januvia is widely prescribed due to its proven efficacy, good tolerability, and low risk of hypoglycemia when used alone or in combination with other oral antidiabetic medicines such as metformin. It is suitable for patients requiring improved glycemic control alongside diet and lifestyle modification.

Available strengths include 25 mg, 50 mg, and 100 mg, allowing flexible dosing based on individual patient needs and renal function.

Medicina Overseas supplies Januvia® tablets for international markets, supporting pharmacies, hospitals, wholesalers, and distributors with reliable sourcing, bulk quantities, and export-compliant documentation.

⚠️ Prescription medicine. To be used only under medical supervision.

✅ KEY USES (OPTIONAL – HIGH CONVERSION)

• Management of type 2 diabetes mellitus

• Improves blood sugar control

• Can be used alone or with metformin

• Well-established global diabetes brand